BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther 2020;5:181. [PMID: 32879300 DOI: 10.1038/s41392-020-00222-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Margiotta A. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal. Int J Mol Sci 2021;22:6342. [PMID: 34198477 DOI: 10.3390/ijms22126342] [Reference Citation Analysis]
2 Butkiewicz D, Gdowicz-Kłosok A, Krześniak M, Rutkowski T, Łasut-Szyszka B, Składowski K. Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2022;14:1844. [PMID: 35406617 DOI: 10.3390/cancers14071844] [Reference Citation Analysis]
3 Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, Cristoferi L, Ciaccio A, Cortinovis D, Invernizzi P, Massironi S. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol 2022;:100737. [PMID: 35809836 DOI: 10.1016/j.aohep.2022.100737] [Reference Citation Analysis]
4 Zhao Y, Wang Q, Xie C, Cai Y, Chen X, Hou Y, He L, Li J, Yao M, Chen S, Wu W, Chen X, Hong A. Peptide ligands targeting FGF receptors promote recovery from dorsal root crush injury via AKT/mTOR signaling. Theranostics 2021;11:10125-47. [PMID: 34815808 DOI: 10.7150/thno.62525] [Reference Citation Analysis]
5 Garcia-Padilla C, Hernandez-Torres F, Lozano-Velasco E, Dueñas A, Muñoz-Gallardo MDM, Garcia-Valencia IS, Palencia-Vincent L, Aranega A, Franco D. The Role of Bmp- and Fgf Signaling Modulating Mouse Proepicardium Cell Fate. Front Cell Dev Biol 2021;9:757781. [PMID: 35059396 DOI: 10.3389/fcell.2021.757781] [Reference Citation Analysis]
6 Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, Driskell RR, Rosenthal N, Biernaskie J, Horsley V. Fibroblasts: Origins, definitions, and functions in health and disease. Cell 2021;184:3852-72. [PMID: 34297930 DOI: 10.1016/j.cell.2021.06.024] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Kaufmann M, Schaupp AL, Sun R, Coscia F, Dendrou CA, Cortes A, Kaur G, Evans HG, Mollbrink A, Navarro JF, Sonner JK, Mayer C, DeLuca GC, Lundeberg J, Matthews PM, Attfield KE, Friese MA, Mann M, Fugger L. Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nat Neurosci 2022. [PMID: 35726057 DOI: 10.1038/s41593-022-01097-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mao C, Dong W, Lu J, Zhang Z, Wu H, Ghavamian A, Bi D, Gao P, Liu Z, Ding S. βKlotho Inhibits Cell Proliferation by Downregulating ELK4 and Predicts Favorable Prognosis in Prostate Cancer. Cancer Manag Res 2021;13:6377-87. [PMID: 34408497 DOI: 10.2147/CMAR.S320490] [Reference Citation Analysis]
9 Elangovan M, Ka J, Pak B, Choi W, Oh SR, Jin SW, Yoo YJ. Ubiquitin-conjugating enzyme V variant 1 enables cellular responses toward fibroblast growth factor signaling in endothelium. FASEB J 2022;36:e22103. [PMID: 34921695 DOI: 10.1096/fj.202100808RRR] [Reference Citation Analysis]
10 Wei L, Tan J, Li L, Wang H, Liu S, Chen J, Weng Y, Liu T. Chitosan/Alginate Hydrogel Dressing Loaded FGF/VE-Cadherin to Accelerate Full-Thickness Skin Regeneration and More Normal Skin Repairs. Int J Mol Sci 2022;23:1249. [PMID: 35163172 DOI: 10.3390/ijms23031249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Mukherjee T, Behl T, Sehgal A, Bhatia S, Singh H, Bungau S. Exploring the molecular role of endostatin in diabetic neuropathy. Mol Biol Rep 2021;48:1819-36. [PMID: 33559819 DOI: 10.1007/s11033-021-06205-3] [Reference Citation Analysis]
12 Small CM, Healey HM, Currey MC, Beck EA, Catchen J, Lin ASP, Cresko WA, Bassham S. Leafy and weedy seadragon genomes connect genic and repetitive DNA features to the extravagant biology of syngnathid fishes. Proc Natl Acad Sci U S A 2022;119:e2119602119. [PMID: 35733255 DOI: 10.1073/pnas.2119602119] [Reference Citation Analysis]
13 Szybowska P, Kostas M, Wesche J, Haugsten EM, Wiedlocha A. Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling. Cells 2021;10:1342. [PMID: 34071546 DOI: 10.3390/cells10061342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Marques C, Reis CA, Vivès RR, Magalhães A. Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression. Front Oncol 2021;11:778752. [PMID: 34858858 DOI: 10.3389/fonc.2021.778752] [Reference Citation Analysis]
15 Tritten L, Burkman EJ, Clark T, Verocai GG. Secretory microRNA Profiles of Third- and Fourth-Stage Dirofilaria immitis Larvae with Different Macrocyclic Lactone Susceptibility: In Search of Biomarkers for Early Detection of Infection. Pathogens 2021;10:786. [PMID: 34206439 DOI: 10.3390/pathogens10070786] [Reference Citation Analysis]
16 Kim JW, Kim R, Choi H, Lee SJ, Bae GU. Understanding of sarcopenia: from definition to therapeutic strategies. Arch Pharm Res 2021. [PMID: 34537916 DOI: 10.1007/s12272-021-01349-z] [Reference Citation Analysis]
17 Cecchini A, Cornelison DDW. Eph/Ephrin-Based Protein Complexes: The Importance of cis Interactions in Guiding Cellular Processes. Front Mol Biosci 2022;8:809364. [DOI: 10.3389/fmolb.2021.809364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Larsen SV, Holven KB, Christensen JJ, Flatberg A, Rundblad A, Leder L, Blomhoff R, Telle-Hansen V, Kolehmainen M, Carlberg C, Myhrstad MC, Thoresen M, Ulven SM. Replacing Saturated Fat with Polyunsaturated Fat Modulates Peripheral Blood Mononuclear Cell Gene Expression and Pathways Related to Cardiovascular Disease Risk Using a Whole Transcriptome Approach. Mol Nutr Food Res 2021;:e2100633. [PMID: 34708513 DOI: 10.1002/mnfr.202100633] [Reference Citation Analysis]
19 Ferrao Blanco MN, Domenech Garcia H, Legeai-Mallet L, van Osch GJVM. Tyrosine kinases regulate chondrocyte hypertrophy: promising drug targets for Osteoarthritis. Osteoarthritis Cartilage 2021:S1063-4584(21)00838-4. [PMID: 34284112 DOI: 10.1016/j.joca.2021.07.003] [Reference Citation Analysis]
20 Trivedi N, Kumar D. Fibroblast growth factor and kidney disease: Updates for emerging novel therapeutics. J Cell Physiol 2021. [PMID: 34196395 DOI: 10.1002/jcp.30497] [Reference Citation Analysis]
21 Farnsworth DA, Chen YT, de Rappard Yuswack G, Lockwood WW. Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer. Cells 2021;10:3553. [DOI: 10.3390/cells10123553] [Reference Citation Analysis]
22 Wang Y, Liu G, Liu R, Wei M, Zhang J, Sun C. EPS364, a Novel Deep-Sea Bacterial Exopolysaccharide, Inhibits Liver Cancer Cell Growth and Adhesion. Mar Drugs 2021;19:171. [PMID: 33809909 DOI: 10.3390/md19030171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Loda A, Turati M, Semeraro F, Rezzola S, Ronca R. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives. Int J Mol Sci 2022;23:3835. [PMID: 35409195 DOI: 10.3390/ijms23073835] [Reference Citation Analysis]
24 Bussolari C, Palumbo D, Fominsky E, Nardelli P, De Lorenzo R, Vitali G, De Cobelli F, Rovere-Querini P, Scandroglio AM. Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019. Front Med (Lausanne) 2021;8:766486. [PMID: 34778326 DOI: 10.3389/fmed.2021.766486] [Reference Citation Analysis]
25 Beri N. Unmet needs in the treatment of intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements. Future Oncol 2022. [PMID: 35081733 DOI: 10.2217/fon-2021-1089] [Reference Citation Analysis]
26 Bregni G, Beck B. Toward Targeted Therapies in Oesophageal Cancers: An Overview. Cancers (Basel) 2022;14:1522. [PMID: 35326673 DOI: 10.3390/cancers14061522] [Reference Citation Analysis]
27 Pereira G, Guo Y, Silva E, Silva MF, Bevilacqua C, Charpigny G, Lopes-da-costa L, Humblot P. Subclinical endometritis differentially affects the transcriptomic profiles of endometrial glandular, luminal, and stromal cells of postpartum dairy cows. Journal of Dairy Science 2022. [DOI: 10.3168/jds.2022-21811] [Reference Citation Analysis]
28 Hao Y, Xiao Y, Liao X, Tang S, Xie X, Liu R, Chen Q. FGF8 induces epithelial-mesenchymal transition and promotes metastasis in oral squamous cell carcinoma. Int J Oral Sci 2021;13:6. [PMID: 33649301 DOI: 10.1038/s41368-021-00111-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Farooq M, Khan AW, Kim MS, Choi S. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells 2021;10:3242. [PMID: 34831463 DOI: 10.3390/cells10113242] [Reference Citation Analysis]
30 Luthold C, Hallal T, Labbé DP, Bordeleau F. The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance? Cancers (Basel) 2022;14:2887. [PMID: 35740556 DOI: 10.3390/cancers14122887] [Reference Citation Analysis]
31 Mahmood HA, Tomas Bort E, Walker AJ, Grose RP, Chioni AM. FGF signalling facilitates cervical cancer progression. FEBS J 2021. [PMID: 34951738 DOI: 10.1111/febs.16331] [Reference Citation Analysis]
32 Liu D, Liu H, Gan J, Zeng S, Zhong F, Zhang B, Zhang Z, Zhang S, Jiang L, Wang G, Chen Y, Kong FS, Fang W, Wang L. LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC. Front Pharmacol 2022;13:918317. [DOI: 10.3389/fphar.2022.918317] [Reference Citation Analysis]
33 Zhang Y, Liu P, Su W, Aodeng G, Zhao H. Fibroblast Growth Factor 3 Is Associated with Tongue Squamous Cell Carcinoma: A Controlled Study. Comput Math Methods Med 2022;2022:3331119. [PMID: 35720042 DOI: 10.1155/2022/3331119] [Reference Citation Analysis]
34 Parveen N, Lin YL, Chou RH, Sun CM, Yu C. Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade. Front Chem 2021;9:764200. [PMID: 35047478 DOI: 10.3389/fchem.2021.764200] [Reference Citation Analysis]
35 Tey S, Mueller M, Reilly M, Switalski C, Robertson S, Sakanaka-yokoyama M, Suzuki M, Pan Z. Cell Surface Proteins for Enrichment and In Vitro Characterization of Human Pluripotent Stem Cell-Derived Myogenic Progenitors. Stem Cells International 2022;2022:1-21. [DOI: 10.1155/2022/2735414] [Reference Citation Analysis]
36 Xie H, Alem Glison DM, Kim RD. FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential. Expert Opin Investig Drugs 2021;:1-8. [PMID: 34913780 DOI: 10.1080/13543784.2022.2017879] [Reference Citation Analysis]
37 Hoshiyama J, Okada Y, Hayata Y, Eguchi A, Ueki R, Sando S. Characterization of a DNA Aptamer with High Specificity toward Fibroblast Growth Factor Receptor 1. Chem Lett 2021;50:1949-52. [DOI: 10.1246/cl.210505] [Reference Citation Analysis]
38 Li N, Lin SM, Li Y, Sun J, Zhang L, Chen M. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia. Stem Cell Res 2021;53:102322. [PMID: 33848795 DOI: 10.1016/j.scr.2021.102322] [Reference Citation Analysis]
39 Rajendran R, Rajendran V, Giraldo-Velasquez M, Megalofonou FF, Gurski F, Stadelmann C, Karnati S, Berghoff M. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci 2021;22:9495. [PMID: 34502405 DOI: 10.3390/ijms22179495] [Reference Citation Analysis]
40 Krzyscik MA, Opaliński Ł, Szymczyk J, Otlewski J. Cyclic and dimeric fibroblast growth factor 2 variants with high biomedical potential. Int J Biol Macromol 2022;218:243-58. [PMID: 35878661 DOI: 10.1016/j.ijbiomac.2022.07.105] [Reference Citation Analysis]
41 Kumar V, Goutam RS, Park S, Lee U, Kim J. Functional Roles of FGF Signaling in Early Development of Vertebrate Embryos. Cells 2021;10:2148. [PMID: 34440915 DOI: 10.3390/cells10082148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Karl K, Hristova K. Pondering the mechanism of receptor tyrosine kinase activation: The case for ligand-specific dimer microstate ensembles. Curr Opin Struct Biol 2021;71:193-9. [PMID: 34399300 DOI: 10.1016/j.sbi.2021.07.003] [Reference Citation Analysis]
43 Tao QR, Chu YM, Wei L, Tu C, Han YY. Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review). Mol Med Rep 2021;23:260. [PMID: 33655322 DOI: 10.3892/mmr.2021.11899] [Reference Citation Analysis]
44 Hedayati MA, Khani D, Bashiri H. Genotyping Helicobacter pylori and fgf7 gene expression in gastric cancer. Mol Biol Rep 2022. [PMID: 35799083 DOI: 10.1007/s11033-022-07732-3] [Reference Citation Analysis]
45 Pagano K, Carminati L, Tomaselli S, Molinari H, Taraboletti G, Ragona L. Molecular Basis of the Antiangiogenic Action of Rosmarinic Acid, a Natural Compound Targeting Fibroblast Growth Factor-2/FGFR Interactions. Chembiochem 2021;22:160-9. [PMID: 32975328 DOI: 10.1002/cbic.202000610] [Reference Citation Analysis]
46 Kelam N, Racetin A, Katsuyama Y, Vukojević K, Kostić S. Immunohistochemical Expression Pattern of FGFR1, FGFR2, RIP5, and HIP2 in Developing and Postnatal Kidneys of Dab1-/- (yotari) Mice. Int J Mol Sci 2022;23:2025. [PMID: 35216141 DOI: 10.3390/ijms23042025] [Reference Citation Analysis]
47 Deng J, Liu Y, Liu Y, Li W, Nie X. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy. J Inflamm Res 2021;14:5273-90. [PMID: 34703268 DOI: 10.2147/JIR.S334996] [Reference Citation Analysis]
48 Liu Z, Liu J, Chen T, Wang Y, Shi A, Li K, Li X, Qiu B, Zheng L, Zhao L, Shu L, Lian S, Huang S, Zhang Z, Xu Y. Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway. Oncogene. [DOI: 10.1038/s41388-022-02313-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Mongre RK, Mishra CB, Shukla AK, Prakash A, Jung S, Ashraf-Uz-Zaman M, Lee MS. Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure? Int J Mol Sci 2021;22:11659. [PMID: 34769090 DOI: 10.3390/ijms222111659] [Reference Citation Analysis]
50 Sirohi VK, Medrano TI, Mesa AM, Kannan A, Bagchi IC, Cooke PS. Regulation of AKT Signaling in Mouse Uterus. Endocrinology 2022;163:bqab233. [PMID: 34791100 DOI: 10.1210/endocr/bqab233] [Reference Citation Analysis]
51 Schaffrin-nabe D, Schuster S, Tannapfel A, Voigtmann R. Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types. Front Med 2022;9:841441. [DOI: 10.3389/fmed.2022.841441] [Reference Citation Analysis]
52 Gelbrich N, Miebach L, Berner J, Freund E, Saadati F, Schmidt A, Stope M, Zimmermann U, Burchardt M, Bekeschus S. Non-invasive medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues. J Adv Res 2022:S2090-1232(22)00166-7. [PMID: 35931323 DOI: 10.1016/j.jare.2022.07.012] [Reference Citation Analysis]
53 Roth DM, Souter K, Graf D. Craniofacial sutures: Signaling centres integrating mechanosensation, cell signaling, and cell differentiation. Eur J Cell Biol 2022;101:151258. [PMID: 35908436 DOI: 10.1016/j.ejcb.2022.151258] [Reference Citation Analysis]
54 Jin C, Yuan M, Bu H, Jin C, Tomao F. Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/4880355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Poźniak M, Zarzycka W, Porębska N, Knapik A, Marczakiewicz-Perera P, Zakrzewska M, Otlewski J, Opaliński Ł. FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs. Biomolecules 2021;11:1088. [PMID: 34439755 DOI: 10.3390/biom11081088] [Reference Citation Analysis]
56 Mendoza FA, Piera-Velazquez S, Jimenez SA. Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition. Transl Res 2021;231:139-58. [PMID: 33422651 DOI: 10.1016/j.trsl.2021.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Cheng L, Liu W, Zhong C, Ni P, Ni S, Wang Q, Zhang Q, Zhang J, Liu J, Xu M, Yao X, Cen X, Wang G, Jiang C, Zhou F. Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy. J Ethnopharmacol 2021;270:113770. [PMID: 33388426 DOI: 10.1016/j.jep.2020.113770] [Reference Citation Analysis]
58 Zha Z, Liu Y, Miao Y, Liao S, Wang SY, Tang H, Yin H. Preparation and characterization of 2-deacetyl-3-O-sulfo-heparosan and its antitumor effects via the fibroblast growth factor receptor pathway. Int J Biol Macromol 2022;201:47-58. [PMID: 34998873 DOI: 10.1016/j.ijbiomac.2021.12.098] [Reference Citation Analysis]
59 Nita A, Abraham SP, Krejci P, Bosakova M. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling. Cells 2021;10:1445. [PMID: 34207779 DOI: 10.3390/cells10061445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Bird RP, Eskin NAM. The emerging role of phosphorus in human health. Adv Food Nutr Res 2021;96:27-88. [PMID: 34112356 DOI: 10.1016/bs.afnr.2021.02.001] [Reference Citation Analysis]
61 Fioretti T, Cevenini A, Zanobio M, Raia M, Sarnataro D, Cattaneo F, Ammendola R, Esposito G. Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates HOXA9 Gene Expression in t(4;11) Leukemia Cells. Int J Mol Sci 2021;22:4623. [PMID: 33924850 DOI: 10.3390/ijms22094623] [Reference Citation Analysis]
62 Du X, Mcmanus DP, Fogarty CE, Jones MK, You H. Schistosoma mansoni Fibroblast Growth Factor Receptor A Orchestrates Multiple Functions in Schistosome Biology and in the Host-Parasite Interplay. Front Immunol 2022;13:868077. [DOI: 10.3389/fimmu.2022.868077] [Reference Citation Analysis]
63 Łukawska A, Mulak A. Physiological and pathophysiological role of endocrine fibroblast growth factors. Postępy Higieny i Medycyny Doświadczalnej 2022;76:39-53. [DOI: 10.2478/ahem-2022-0045] [Reference Citation Analysis]
64 Thomas J, Sonpavde G. Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer. Cancers 2022;14:1795. [DOI: 10.3390/cancers14071795] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Chakrabarti S, Finnes HD, Mahipal A. Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management. Expert Opinion on Drug Metabolism & Toxicology. [DOI: 10.1080/17425255.2022.2039118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
66 Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH, Khoo CS, Kumar J. Alzheimer’s Disease: An Update and Insights Into Pathophysiology. Front Aging Neurosci 2022;14:742408. [DOI: 10.3389/fnagi.2022.742408] [Reference Citation Analysis]
67 Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Dis 2022;:e1549. [PMID: 35142107 DOI: 10.1002/wsbm.1549] [Reference Citation Analysis]
68 Roy S, Banerjee P, Ekser B, Bayless K, Zawieja D, Alpini G, Glaser SS, Chakraborty S. Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer. Am J Pathol 2021;191:2052-63. [PMID: 34509441 DOI: 10.1016/j.ajpath.2021.08.011] [Reference Citation Analysis]
69 Porębska N, Knapik A, Poźniak M, Krzyścik MA, Zakrzewska M, Otlewski J, Opaliński Ł. Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing Cancers. Biomacromolecules 2021;22:5349-62. [PMID: 34855396 DOI: 10.1021/acs.biomac.1c01280] [Reference Citation Analysis]
70 Pryimak N, Zaiachuk M, Kovalchuk O, Kovalchuk I. The Potential Use of Cannabis in Tissue Fibrosis. Front Cell Dev Biol 2021;9:715380. [PMID: 34708034 DOI: 10.3389/fcell.2021.715380] [Reference Citation Analysis]
71 Cheah YJ, Buyong MR, Mohd Yunus MH. Wound Healing with Electrical Stimulation Technologies: A Review. Polymers (Basel) 2021;13:3790. [PMID: 34771347 DOI: 10.3390/polym13213790] [Reference Citation Analysis]
72 Epstein RJ, Tian LJ, Gu YF. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology. J Oncol 2021;2021:9955456. [PMID: 34007277 DOI: 10.1155/2021/9955456] [Reference Citation Analysis]
73 Jia M, Guan C, Tao J, Zhou Y, Yan L. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/5042762] [Reference Citation Analysis]
74 Vogeley C, Rolfes KM, Krutmann J, Haarmann-Stemmann T. The Aryl Hydrocarbon Receptor in the Pathogenesis of Environmentally-Induced Squamous Cell Carcinomas of the Skin. Front Oncol 2022;12:841721. [PMID: 35311158 DOI: 10.3389/fonc.2022.841721] [Reference Citation Analysis]
75 Marcinkowska E. Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets. Nutrients 2022;14:2851. [DOI: 10.3390/nu14142851] [Reference Citation Analysis]
76 Fujitani M, Otani Y, Miyajima H. Do Neurotrophins Connect Neurological Disorders and Heart Diseases? Biomolecules 2021;11:1730. [PMID: 34827728 DOI: 10.3390/biom11111730] [Reference Citation Analysis]
77 Typiak M, Kulesza T, Rachubik P, Rogacka D, Audzeyenka I, Angielski S, Saleem MA, Piwkowska A. Role of Klotho in Hyperglycemia: Its Levels and Effects on Fibroblast Growth Factor Receptors, Glycolysis, and Glomerular Filtration. Int J Mol Sci 2021;22:7867. [PMID: 34360633 DOI: 10.3390/ijms22157867] [Reference Citation Analysis]
78 Yang R, Zhan Y, Li Y, Dai S, He S, Ye C, Meng L, Chen D, Dong C, Chen L, Chen G, Dong K, Li K, Zheng S, Li J, Yao W, Dong R. The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma. Front Oncol 2022;12:893206. [DOI: 10.3389/fonc.2022.893206] [Reference Citation Analysis]
79 Wang N, Dong Y, Xu X, Shen Y, Huang Z, Yu Y, Liu Z, Gong W, Zhang S, Zheng Y, Song Y, Zhu Z, Jin L, Cong W. Fibroblast growth factor 10 protects against UVB‐induced skin injury by activating the ERK/YAP signalling pathway. Cell Proliferation. [DOI: 10.1111/cpr.13315] [Reference Citation Analysis]
80 Khan W, Ahmad W, Hashem AM, Zakai S, Haque S, Malik MFA, Harakeh S, Haq F. Genomic Relevance of FGFR2 on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients. JCM 2022;11:3093. [DOI: 10.3390/jcm11113093] [Reference Citation Analysis]
81 Mansour MA, Caputo VS, Aleem E. Highlights on selected growth factors and their receptors as promising anticancer drug targets. Int J Biochem Cell Biol 2021;140:106087. [PMID: 34563698 DOI: 10.1016/j.biocel.2021.106087] [Reference Citation Analysis]
82 Wang D, Zhao T, Zhao Y, Yin Y, Huang Y, Cheng Z, Wang B, Liu S, Pan M, Sun D, Wang Z, Zhu G. PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1ΔHBS in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling. Front Pharmacol 2021;12:690535. [PMID: 34149434 DOI: 10.3389/fphar.2021.690535] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Mollica V, Massari F, Rizzo A, Ferrara R, Menta AK, Adashek JJ. Genomics and Immunomics in the Treatment of Urothelial Carcinoma. Current Oncology 2022;29:3499-518. [DOI: 10.3390/curroncol29050283] [Reference Citation Analysis]
84 Poźniak M, Porębska N, Jastrzębski K, Krzyścik MA, Kucińska M, Zarzycka W, Barbach A, Zakrzewska M, Otlewski J, Miączyńska M, Opaliński Ł. Modular self-assembly system for development of oligomeric, highly internalizing and potent cytotoxic conjugates targeting fibroblast growth factor receptors. J Biomed Sci 2021;28:69. [PMID: 34635096 DOI: 10.1186/s12929-021-00767-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Vitale G, Cozzolino A, Malandrino P, Minotta R, Puliani G, Saronni D, Faggiano A, Colao A. Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications. Front Endocrinol (Lausanne) 2021;12:665631. [PMID: 33935975 DOI: 10.3389/fendo.2021.665631] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Garré JM, Bukauskas FF, Bennett MVL. Single channel properties of pannexin-1 and connexin-43 hemichannels and P2X7 receptors in astrocytes cultured from rodent spinal cords. Glia 2022. [PMID: 35915989 DOI: 10.1002/glia.24250] [Reference Citation Analysis]
87 Calanca N, Binato SMS, da Silva SD, Brentani HP, Sennes LU, Pinto CAL, Domingues MAC, Fonseca-Alves CE, Rainho CA, Rogatto SR. Master Regulators of Epithelial-Mesenchymal Transition and WNT Signaling Pathways in Juvenile Nasopharyngeal Angiofibromas. Biomedicines 2021;9:1258. [PMID: 34572445 DOI: 10.3390/biomedicines9091258] [Reference Citation Analysis]
88 Kim Y, Zharkinbekov Z, Sarsenova M, Yeltay G, Saparov A. Recent Advances in Gene Therapy for Cardiac Tissue Regeneration. Int J Mol Sci 2021;22:9206. [PMID: 34502115 DOI: 10.3390/ijms22179206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Murugan NJ, Vigran HJ, Miller KA, Golding A, Pham QL, Sperry MM, Rasmussen-Ivey C, Kane AW, Kaplan DL, Levin M. Acute multidrug delivery via a wearable bioreactor facilitates long-term limb regeneration and functional recovery in adult Xenopus laevis. Sci Adv 2022;8:eabj2164. [PMID: 35080969 DOI: 10.1126/sciadv.abj2164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
90 Cattin J, Formet J, Sartelet H, Lenoir M, Riethmuller D, Collardeau-Frachon S. Expending the Phenotypic Spectrum of Encephalocraniocutaneous Lipomatosis: About a Prenatal Case With Complete Autopsy. Pediatr Dev Pathol 2021;:10935266211040802. [PMID: 34547955 DOI: 10.1177/10935266211040802] [Reference Citation Analysis]
91 Aprajita, Sharma R. Comprehending fibroblast growth factor receptor like 1: Oncogene or tumor suppressor? Cancer Treat Res Commun 2021;29:100472. [PMID: 34689016 DOI: 10.1016/j.ctarc.2021.100472] [Reference Citation Analysis]
92 Szymczyk J, Sluzalska KD, Materla I, Opalinski L, Otlewski J, Zakrzewska M. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance. Cancers (Basel) 2021;13:5796. [PMID: 34830951 DOI: 10.3390/cancers13225796] [Reference Citation Analysis]
93 Ocon A, Lokineni S, Korman B. Understanding and Therapeutically Targeting the Scleroderma Myofibroblast. Curr Treat Options in Rheum. [DOI: 10.1007/s40674-021-00189-8] [Reference Citation Analysis]
94 He M, Cao C, Ni Z, Liu Y, Song P, Hao S, He Y, Sun X, Rao Y. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct Target Ther 2022;7:181. [PMID: 35680848 DOI: 10.1038/s41392-022-00999-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Rajendran R, Böttiger G, Stadelmann C, Karnati S, Berghoff M. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. Cells 2021;10:884. [PMID: 33924474 DOI: 10.3390/cells10040884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Li T, Qing BL, Deng Y, Que XT, Wang CZ, Lu HW, Wang SH, Wang ZJ. Inhibition of Long non-coding RNA zinc finger antisense 1 improves functional recovery and angiogenesis after focal cerebral ischemia via microRNA-144-5p/fibroblast growth factor 7 axis. Bioengineered 2022;13:1702-16. [PMID: 35012442 DOI: 10.1080/21655979.2021.2018093] [Reference Citation Analysis]
97 Hyung S, Han B, Jung J, Kim ST, Hong JY, Park SH, Zang DY, Park JO, Park YS, Kim KM, Kang WK, Lee J. Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing. J Oncol 2022;2022:9714570. [PMID: 35342406 DOI: 10.1155/2022/9714570] [Reference Citation Analysis]
98 Yadav V, Tolwinski N, Saunders TE. Spatiotemporal sensitivity of mesoderm specification to FGFR signalling in the Drosophila embryo. Sci Rep 2021;11:14091. [PMID: 34238963 DOI: 10.1038/s41598-021-93512-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Hari PS, Balakrishnan L, Kotyada C, Everad John A, Tiwary S, Shah N, Sirdeshmukh R. Proteogenomic Analysis of Breast Cancer Transcriptomic and Proteomic Data, Using De Novo Transcript Assembly: Genome-Wide Identification of Novel Peptides and Clinical Implications. Mol Cell Proteomics 2022;21:100220. [PMID: 35227895 DOI: 10.1016/j.mcpro.2022.100220] [Reference Citation Analysis]
100 Wang Y, Liu D, Zhang T, Xia L. FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention. Cancers (Basel) 2021;13:1360. [PMID: 33802841 DOI: 10.3390/cancers13061360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]